Journal of Antimicrobial Chemotherapy (2000) 46, 49-52
© 2000 The British Society for Antimicrobial Chemotherapy
Survey on antibiotic usage in the treatment of urinary tract infections
Klinikum St Elisabeth Straubing GmbH, St Elisabeth Strasse 23, D-94315, Straubing, Germany
Ninety-two clinical microbiologists, infectious disease clinicians and clinicians with an interest in the management of urinary tract infections (UTIs) participated in an interactive session concerning the management of acute uncomplicated lower UTI. The antibacterials considered most appropriate as first-line agents were trimethoprim, co-trimoxazole, pivmecillinam, nitrofurantoin and fluoroquinolones. The current level of usage of fluoroquinolones for lower UTIs was, however, considered inappropriate by most delegates from a ‘societal perspective’, in terms of spread of resistance and potential impact on the environment.
* Corresponding author. Tel: +49-94-21-710-1700; Fax: +49-94-21-710-1015; E-mail: naberk{at}klinikum-straubing.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Wootton, T. R. Walsh, L. Macfarlane, and R. A. Howe Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins J. Antimicrob. Chemother., November 13, 2009; (2009) dkp404v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sandegren, A. Lindqvist, G. Kahlmeter, and D. I. Andersson Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli J. Antimicrob. Chemother., September 1, 2008; 62(3): 495 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Karlowsky, D. J. Hoban, M. R. DeCorby, N. M. Laing, and G. G. Zhanel Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2251 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Holden, M. Totsika, E. Mahler, A. J. Roe, K. Catherwood, K. Lindner, U. Dobrindt, and D. L. Gally Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology, April 1, 2006; 152(Pt 4): 1143 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Lindgren, L. L. Marcusson, D. Sandvang, N. Frimodt-Moller, and D. Hughes Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract Infections Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2343 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miller, A. J. O'Neill, and I. Chopra Escherichia coli Mutators Present an Enhanced Risk for Emergence of Antibiotic Resistance during Urinary Tract Infections Antimicrob. Agents Chemother., January 1, 2004; 48(1): 23 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|